Referências
Principais artigos
Kidney Disease: Improving Global Outcomes (KDIGO) Glomerular Diseases Work Group. KDIGO 2021 Clinical practice guideline for the management of glomerular diseases. Kidney Int. 2021 Oct;100(4s):S1-276.Texto completo Resumo
Sethi S, De Vriese AS, Fervenza FC. Acute glomerulonephritis. Lancet. 2022 Apr 23;399(10335):1646-63. Resumo
Walters GD, Willis NS, Cooper TE, et al. Interventions for renal vasculitis in adults. Cochrane Database Syst Rev. 2020 Jan 13;(1):CD003232.Texto completo Resumo
Artigos de referência
1. Kidney Disease: Improving Global Outcomes (KDIGO) Glomerular Diseases Work Group. KDIGO 2021 Clinical practice guideline for the management of glomerular diseases. Kidney Int. 2021 Oct;100(4s):S1-276.Texto completo Resumo
2. Sethi S, Haas M, Markowitz GS, et al. Mayo Clinic/Renal Pathology Society consensus report on pathologic classification, diagnosis, and reporting of GN. J Am Soc Nephrol. 2016 May;27(5):1278-87.Texto completo Resumo
3. Sethi S, De Vriese AS, Fervenza FC. Acute glomerulonephritis. Lancet. 2022 Apr 23;399(10335):1646-63. Resumo
4. Khanna R. Clinical presentation & management of glomerular diseases: hematuria, nephritic & nephrotic syndrome. Mo Med. 2011 Jan-Feb;108(1):33-6.Texto completo Resumo
5. Moroni G, Ponticelli C. Rapidly progressive crescentic glomerulonephritis: Early treatment is a must. Autoimmun Rev. 2014 Jul;13(7):723-9. Resumo
6. Haas M, Meehan SM, Karrison TG, et al. Changing etiologies of unexplained adult nephrotic syndrome: a comparison of renal biopsy findings from 1976-1979 and 1995-1997. Am J Kidney Dis. 1997 Nov;30(5):621-31. Resumo
7. Heaf JG, Sørensen SS, Hansen A. Increased incidence and improved prognosis of glomerulonephritis: a national 30-year study. Clin Kidney J. 2021 Jun;14(6):1594-602.Texto completo Resumo
8. O'Shaughnessy MM, Hogan SL, Thompson BD, et al. Glomerular disease frequencies by race, sex and region: results from the International Kidney Biopsy Survey. Nephrol Dial Transplant. 2018 Apr 1;33(4):661-9.Texto completo Resumo
9. Satoskar AA, Parikh SV, Nadasdy T. Epidemiology, pathogenesis, treatment and outcomes of infection-associated glomerulonephritis. Nat Rev Nephrol. 2020 Jan;16(1):32-50. Resumo
10. Braden GL, Mulhern JG, O'Shea MH, et al. Changing incidence of glomerular diseases in adults. Am J Kidney Dis. 2000 May;35(5):878-83. Resumo
11. O'Shaughnessy MM, Hogan SL, Poulton CJ, et al. Temporal and demographic trends in glomerular disease epidemiology in the southeastern United States, 1986-2015. Clin J Am Soc Nephrol. 2017 Apr 3;12(4):614-23.Texto completo Resumo
12. Simon P, Ramee MP, Boulahrouz R, et al. Epidemiologic data of primary glomerular diseases in western France. Kidney Int. 2004 Sep;66(3):905-8.Texto completo Resumo
13. Jegatheesan D, Nath K, Reyaldeen R, et al. Epidemiology of biopsy-proven glomerulonephritis in Queensland adults. Nephrology (Carlton). 2016 Jan;21(1):28-34. Resumo
14. Yang Y, Zhang Z, Zhuo L, et al. The spectrum of biopsy-proven glomerular disease in China: a systematic review. Chin Med J (Engl). 2018 Mar 20;131(6):731-5.Texto completo Resumo
15. Hu R, Quan S, Wang Y, et al. Spectrum of biopsy proven renal diseases in Central China: a 10-year retrospective study based on 34,630 cases. Sci Rep. 2020 Jul 3;10(1):10994.Texto completo Resumo
16. GBD Chronic Kidney Disease Collaboration. Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2020 Feb 29;395(10225):709-33.Texto completo Resumo
17. Floege J, Amann K. Primary glomerulonephritides. Lancet. 2016 May 14;387(10032):2036-48. Resumo
18. Couser WG. Glomerulonephritis. Lancet. 1999 May 1;353(9163):1509-15. Resumo
19. Hricik DE, Chung-Park M, Sedor JR. Glomerulonephritis. N Engl J Med. 1998 Sep 24;339(13):888-99. Resumo
20. Couser WG, Johnson RJ. The etiology of glomerulonephritis: roles of infection and autoimmunity. Kidney Int. 2014 Nov;86(5):905-14.Texto completo Resumo
21. Kluth DC, Erwig LP, Rees AJ. Multiple facets of macrophages in renal injury. Kidney Int. 2004 Aug;66(2):542-57.Texto completo Resumo
22. Ikezumi Y, Kanno K, Karasawa T, et al. The role of lymphocytes in the experimental progressive glomerulonephritis. Kidney Int. 2004 Sep;66(3):1036-48.Texto completo Resumo
23. Tipping PG, Holdsworth SR. T cells in glomerulonephritis. Springer Semin Immunopathol. 2003 May;24(4):377-93. Resumo
24. Tanaka T, Kuroiwa T, Ikeuchi H, et al. Human platelets stimulate mesangial cells to produce monocyte chemoattractant protein-1 via the CD40/CD40 ligand pathway and may amplify glomerular injury. J Am Soc Nephrol. 2002 Oct;13(10):2488-96.Texto completo Resumo
25. Nangaku M, Shankland SJ, Couser WG. Cellular response to injury in membranous nephropathy. J Am Soc Nephrol. 2005 May;16(5):1195-204.Texto completo Resumo
26. Couser WG. Pathogenesis and treatment of glomerulonephritis-an update. [in por]. J Bras Nefrol. 2016 Mar;38(1):107-22.Texto completo Resumo
27. Tejani A, Ingulli E. Poststreptococcal glomerulonephritis. Current clinical and pathologic concepts. Nephron. 1990;55(1):1-5. Resumo
28. Donadio JV, Grande JP. IgA nephropathy. N Engl J Med. 2002 Sep 5;347(10):738-48. Resumo
29. Johnson RJ, Couser WG. Hepatitis B infection and renal disease: clinical, immunopathogenetic and therapeutic considerations. Kidney Int. 1990 Feb;37(2):663-76.Texto completo Resumo
30. Johnson RJ, Gretch DR, Yamabe H, et al. Membranoproliferative glomerulonephritis associated with hepatitis C virus infection. N Engl J Med. 1993 Feb 18;328(7):465-70.Texto completo Resumo
31. Klotman PE. HIV-associated nephropathy. Kidney Int. 1999 Sep;56(3):1161-76.Texto completo Resumo
32. Weiner NJ, Goodman JW, Kimmel PL. The HIV-associated renal diseases: Current insight into pathogenesis and treatment. Kidney Int. 2003 May;63(5):1618-31.Texto completo Resumo
33. Seligman VA, Lum RF, Olson JL, et al. Demographic differences in the development of lupus nephritis: a retrospective analysis. Am J Med. 2002 Jun 15;112(9):726-9. Resumo
34. Balow JE. Renal vasculitis. Kidney Int. 1985 Jun;27(6):954-64.Texto completo Resumo
35. Ronco PM. Paraneoplastic glomerulopathies: new insights into an old entity. Kidney Int. 1999 Jul;56(1):355-77.Texto completo Resumo
36. Cohen LJ, Rennke HG, Laubach JP, et al. The spectrum of kidney involvement in lymphoma: a case report and review of the literature. Am J Kidney Dis. 2010 Dec;56(6):1191-6.Texto completo Resumo
37. Li SJ, Chen HP, Chen YH, et al. Renal involvement in non-Hodgkin lymphoma: proven by renal biopsy. PLoS One. 2014;9(4):e95190.Texto completo Resumo
38. Moulin B, Ronco PM, Mougenot B, et al. Glomerulonephritis in chronic lymphocytic leukemia and related B-cell lymphomas. Kidney Int. 1992 Jul;42(1):127-35.Texto completo Resumo
39. Dobrek L. A Synopsis of Current Theories on Drug-Induced Nephrotoxicity. Life (Basel). 2023 Jan 24;13(2):.Texto completo Resumo
40. Fuiano G, Mazza G, Comi N, et al. Current indications for renal biopsy: A questionnaire-based survey. Am J Kidney Dis. 2000 Mar;35(3):448-57. Resumo
41. Walters GD, Willis NS, Cooper TE, et al. Interventions for renal vasculitis in adults. Cochrane Database Syst Rev. 2020 Jan 13;(1):CD003232.Texto completo Resumo
42. Arimura Y, Muso E, Fujimoto S, et al. Evidence-based clinical practice guidelines for rapidly progressive glomerulonephritis 2014. Clin Exp Nephrol. 2016 Jun;20(3):322-41.Texto completo Resumo
43. Natale P, Palmer SC, Ruospo M, et al. Immunosuppressive agents for treating IgA nephropathy. Cochrane Database Syst Rev. 2020 Mar 12;(3):CD003965.Texto completo Resumo
44. Laczika K, Knapp S, Derfler K, et al. Immunoadsorption in Goodpasture's syndrome. Am J Kidney Dis. 2000 Aug;36(2):392-5. Resumo
45. Kronbichler A, Jayne DR, Mayer G. Frequency, risk factors and prophylaxis of infection in ANCA-associated vasculitis. Eur J Clin Invest. 2015 Mar;45(3):346-68. Resumo
46. Bolton WK. Goodpasture's syndrome. Kidney Int. 1996 Nov;50(5):1753-66.Texto completo Resumo
O uso deste conteúdo está sujeito ao nosso aviso legal